These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 3960693

  • 1. The quinolones in chronic bronchitis.
    Davies BI, Maesen FP, Teengs JP, Baur C.
    Pharm Weekbl Sci; 1986 Feb 21; 8(1):53-9. PubMed ID: 3960693
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Temafloxacin in acute purulent exacerbations of chronic bronchitis.
    Davies BI, Maesen FP, Gubbelmans HL, Cremers HM.
    J Antimicrob Chemother; 1990 Aug 21; 26(2):237-46. PubMed ID: 2120178
    [Abstract] [Full Text] [Related]

  • 7. Respiratory infections: clinical experiences with the new quinolones.
    Davies BI, Maesen FP.
    Pharm Weekbl Sci; 1987 Dec 11; 9 Suppl():S53-7. PubMed ID: 3438151
    [Abstract] [Full Text] [Related]

  • 8. Quinolones in the treatment of bronchopulmonary infections.
    Thys JP.
    Rev Infect Dis; 1988 Dec 11; 10 Suppl 1():S212-7. PubMed ID: 3279495
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis.
    Maesen FP, Davies BI, Teengs JP, Baur C.
    Eur J Respir Dis Suppl; 1986 Dec 11; 146():585-90. PubMed ID: 3465584
    [No Abstract] [Full Text] [Related]

  • 12. Pefloxacin in acute exacerbations of chronic bronchitis.
    Maesen FP, Davies BI, Teengs JP.
    J Antimicrob Chemother; 1985 Sep 11; 16(3):379-88. PubMed ID: 3863811
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis.
    Klietmann W, Cesana M, Rondel RK, Focht J.
    Antimicrob Agents Chemother; 1993 Nov 11; 37(11):2298-306. PubMed ID: 8285609
    [Abstract] [Full Text] [Related]

  • 15. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
    DeAbate CA, Henry D, Bensch G, Jubran A, Chodosh S, Harper L, Tipping D, Talbot GH.
    Chest; 1998 Jul 11; 114(1):120-30. PubMed ID: 9674458
    [Abstract] [Full Text] [Related]

  • 16. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
    Wijnands WJ, Vree TB, Baars AM, van Herwaarden CL.
    Drugs; 1987 Jul 11; 34 Suppl 1():159-69. PubMed ID: 3481317
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
    Thys JP, Jacobs F, Byl B.
    Eur J Clin Microbiol Infect Dis; 1991 Apr 11; 10(4):304-15. PubMed ID: 1864291
    [Abstract] [Full Text] [Related]

  • 19. A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology.
    Kemper P, Köhler D.
    Am J Med; 1992 Apr 06; 92(4A):98S-102S. PubMed ID: 1316079
    [Abstract] [Full Text] [Related]

  • 20. The influence of quinolone derivatives on theophylline clearance.
    Wijnands WJ, Vree TB, van Herwaarden CL.
    Br J Clin Pharmacol; 1986 Dec 06; 22(6):677-83. PubMed ID: 3567014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.